Allergan wins lawsuit against Imprimis, but jury awards only $48,500

A federal jury has ordered Imprimis Pharmaceuticals to pay $48,500 in damages to Allergan, far less than Allergan was seeking, for lost business due to false advertising by the compounding company.
In the lawsuit against Harrow Health Inc., formerly known as Imprimis Pharmaceuticals, Allergan requested damages of more than $7.2 million in lost profits and as much as $54 million in profit disgorgement, according to a Form 8-K filing to the U.S Securities and Exchange Commission by Harrow Health.
The case, which was tried in the U.S. District Court for (Read more...)

Full Story →